MAY COMMIT OVER $1 BN TO MODERNA FOR VACCINE: CIPLA

Seeking fast-track approvals to bring Moderna’s single-dose Covid-19 booster vaccine in India expeditiously, Cipla has requested the government for indemnification and exemptions from price capping, bridging trials and basic customs duty, while stating that it is close to committing over $1-billion as advance to the US major, sources said on Monday.

The Indian pharma giant has said its discussions with Moderna on the Covid-19 booster vaccine are nearing finalisation and for that, they are seeking the “partnership and support of the government to make this programme successful”.

Requesting the government to provide confirmation, Cipla has said such an assurance will help make this significant financial commitment of more than over ₹7,250 crore advance to Moderna for its booster vaccine in India.